Trial Profile
Phase II Study of Goserelin for Ovarian Protection in Premenopausal Patients Receiving Cyclophosphamide Containing Chemotherapy: Menstruation Outcome
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Goserelin (Primary) ; Cyclophosphamide
- Indications Primary ovarian insufficiency
- Focus Therapeutic Use
- 27 Mar 2018 New trial record